| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
After the AUGUSTUS Trial, Should Apixaban Be the Only Direct Oral Anticoagulant to Be Used in Triple Therapy in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention?
|
Rubboli, Andrea
|
|
2019
|
33 |
4 |
p. 499-500
|
artikel
|
| 2 |
Attainment of Guideline-Directed Medical Treatment in Stable Ischemic Heart Disease Patients With and Without Chronic Kidney Disease
|
Koutroumpakis, Efstratios
|
|
2019
|
33 |
4 |
p. 443-451
|
artikel
|
| 3 |
Effect of a Therapeutic Strategy Guided by Lung Ultrasound on 6-Month Outcomes in Patients with Heart Failure: Randomized, Multicenter Trial (EPICC Study)
|
Bailón, Manuel Méndez
|
|
2019
|
33 |
4 |
p. 453-459
|
artikel
|
| 4 |
Effect of Tofogliflozin on Systolic and Diastolic Cardiac Function in Type 2 Diabetic Patients
|
Otagaki, Munemitsu
|
|
2019
|
33 |
4 |
p. 435-442
|
artikel
|
| 5 |
Effects of PDE-5 Inhibition on the Cardiopulmonary System After 2 or 4 Weeks of Chronic Hypoxia
|
Nydegger, Coline
|
|
2019
|
33 |
4 |
p. 407-414
|
artikel
|
| 6 |
Efficacy of Antiplatelet Agent Usage for Primary and Secondary Prevention in Dialysis Patients: a Nationwide Data Survey and Propensity Analysis
|
Chen, Zheng-Wei
|
|
2019
|
33 |
4 |
p. 471-479
|
artikel
|
| 7 |
Long-Term Efficacy and Safety of Immunomodulatory Therapy for Atherosclerosis
|
Thota, Lakshmi Narasimha
|
|
2019
|
33 |
4 |
p. 385-398
|
artikel
|
| 8 |
Obesity-Related Genetic Determinants of Heart Failure Prognosis
|
Agra, R. M.
|
|
2019
|
33 |
4 |
p. 415-424
|
artikel
|
| 9 |
Oral Anticoagulation for Atrial Fibrillation Thromboembolism Prophylaxis in the Chronic Kidney Disease Population: the State of the Art in 2019
|
Zhang, Lane
|
|
2019
|
33 |
4 |
p. 481-488
|
artikel
|
| 10 |
Pirfenidone in Heart Failure with Preserved Ejection Fraction—Rationale and Design of the PIROUETTE Trial
|
Lewis, Gavin A.
|
|
2019
|
33 |
4 |
p. 461-470
|
artikel
|
| 11 |
Resolvin D1 Attenuates Myocardial Infarction in a Rodent Model with the Participation of the HMGB1 Pathway
|
Liu, Rui
|
|
2019
|
33 |
4 |
p. 399-406
|
artikel
|
| 12 |
Safe and Efficacious Use of 1-Month Triple Therapy in Patients with Atrial Fibrillation and High Bleeding Risk Undergoing PCI
|
Sambola, Antonia
|
|
2019
|
33 |
4 |
p. 425-433
|
artikel
|
| 13 |
The Role of Non-coding RNAs in Ischemic Myocardial Reperfusion Injury
|
Siebert, Vince
|
|
2019
|
33 |
4 |
p. 489-498
|
artikel
|
Tijdschrift beschrijving